Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumours
JP Delord, JM Tourani, F Lefresne, A Pétain… - Cancer chemotherapy …, 2013 - Springer
Purpose Vinflunine ditartrate is a microtubule inhibitor belonging to the vinca alkaloid family.
This phase I study was carried out to evaluate the maximal tolerated dose, the safety profile …
This phase I study was carried out to evaluate the maximal tolerated dose, the safety profile …